DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel, Doxorubicin|DRUG: Docetaxel, Doxorubicin, Cyclophosphamide
Sponsor: Peking Union Medical College Hospital